The Management of Chronic Myeloid Leukemia in the Era of Second Generation Tyrosine Kinase Inhibitors

Ibrahim  C. HAZNEDAROGLU; Mustafa  CETINER; Osman  ILHAN

International Journal of Hematology and Oncology 2025, Vol 35, Num 1 (Special Issue) Page(s): 001-003

Back | Table of Contents | PDF | Mail to Author |

The Management of Chronic Myeloid Leukemia in the Era of Second Generation Tyrosine Kinase Inhibitors

Ibrahim C. HAZNEDAROGLU¹, Mustafa CETINER², Osman ILHAN³

¹Hacettepe University Faculty of Medicine, Department of Hematology, Ankara, TURKEY
²American Hospital Department of Hematology, Istanbul, TURKEY
³Ankara University Faculty of Medicine, Department of Hematology, Ankara, TURKEY

Back | Table of Contents | PDF | Mail to Author |